Efficacy of intra lesional injection of 5-flourouracil on keloid scar: A prospective open clinical trial


  • Banoo Dhahir Latif MCHB. Shahid Jabar Dermatological Teaching Center, Sulaimani Directorate of Health, Sulaimaniyah, Iraq,
  • Mohammed Yousif Saeed MBCHB, FIBMS. Asst. Prof. Department of Medicine, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq,
  • Darseem Muhammed Abdulla MBCHB, FIBMS. Lecturer. Department of Medicine, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq




Antineoplastic agent, Monotherapy, Prospective-clinical trial study, Skin disorder


Background and objectives: The management of keloids stayed unsatisfactory. Intralesional 5-fluorouracil has not been broadly and intensively studied as a monotherapy in the treatment of keloids worldwide. So, the aim of this study was to evaluate the efficacy and safety of intralesional injection of 5-flourouracil in patients with keloids. 

Methods: In this prospective clinical trial study, a total of 20 patients aged >18 years at Shahid Jabar Dermatological Teaching Center, Sulaimaniyah, Iraq, from January 2022 to August 2022 were enrolled. Patients were treated at 1-week interval with intralesional injection of 5-flurouracil (50 mg/mL) at maximum of 6 sessions. Average injection volume was 0.2 mL/cm2. All patients were followed up for 6 months.

Results: Most of the patients were aged <50 years (90%) with no family history of keloid (75%). Additionally, 45% of patients had keloid in the trunk region with a size of ?10 cm2 (65%). Most patients (80%) had the disease for ?5 years that caused by inflammation (55%), especially skin type IV (65%). After 6 sessions of treatment, 70% of patients showed moderate improvement, while 30% of patients showed minimum improvement. The main adverse effects after 6 sessions of treatment were hyperpigmentation in 3 patients, bullae in 2 patients, and tissue sloughing only in 1 patient. A significant correlation was found between the patient’s response and age/keloid location. Moreover, mean Redness, Elevation, Hardness, Itching, and Tenderness score after treatment was significantly lower than before treatment (p<0.001).

Conclusions: Our results concluded that 5-flurouracil is a safe and effective therapy for the treatment of keloids.


Download data is not yet available.


Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43:S3-S18.

Sharquie KE, Al?Dhalimi MA. Keloid in Iraqi patients: a clinicohistopathologic study. Dermatol Surg. 2003;29(8):847-51.

Glass II D. Current understanding of the genetic causes of keloid formation. J Investig Dermatol Symp Proc. 2017;18(2):S50-S53.

Mofikoya B, Adeyemo W, Ugburo A. An overview of biological basis of pathologic scarring. Niger Postgrad Med J. 2012;19(1):40-5.

Kim H-D, Hwang S-M, Lim K-R, et al. Recurrent auricular keloids during pregnancy. Arch Plast Surg. 2013;40(01):70-2.

Wang JC, Fort CL, Hom DB. Location propensity for keloids in the head and neck. Facial Plast Surg Aesthet Med. 2021;23(1):59-64.

Boahene K, Brissett AE, Jones LR. Facial plastic surgery controversies: keloids. Facial Plast Surg Clin. 2018;26(2):105-12.

Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5-fluorouracil alone vs. intralesional triamcinolone acetonide with 5-fluorouracil. J Pak Associ Dermatol. 2012;22(1):35-40.

Zhu Z, Kong W, Wang H, et al, Clinical status of hospitalized keloid cases from 2013 to 2018. Burns. 2022;48(8):1874-84.

Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al, Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52(3):474-9.

Saki N, Mokhtari R, Nozari F. Comparing the efficacy of intralesional triamcinolone acetonide with verapamil in treatment of keloids: A randomized controlled trial. Dermatol Pract Conceptual. 2019;9(1):4.

Bijlard E, Steltenpool S, Niessen FB. Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta DV. 2015;95(7):778-82.

Srivastava S, Patil AN, Prakash C, et al, Comparison of intralesional triamcinolone acetonide, 5-fluorouracil, and their combination for the treatment of keloids. Adv Wound Care. 2017;6(11):393-400.

Uzair M, Butt G, Khurshid K, et al, Comparison of intralesional triamcinolone and intralesional verapamil in the treatment of keloids. Our Dermatol Online. 2015;6(3):280.

Shah VV, Aldahan AS, Mlacker S, et al, 5-fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther. 2016;6(2):169-83.

Mustoe TA, Cooter RD, Gold MH, et al, International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-71.

Sharquie K, Noaimi A, Al-Karhi M. Debulking of keloid combined with intralesional injection of methotrexate and triamcinolone versus intralesional injection of methotrexate and triamcinolone. J Clin Dermatol Ther. 2014;1(3):8-21.

Prabhu A, Sreekar H, Powar R, et al. A randomized controlled trial comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc. 2012;39(1):19.

Saha AK, Mukhopadhyay M. A comparative clinical study on role of 5-flurouracil versus triamcinolone in the treatment of keloids. Ind J Surg. 2012;74(4):326-9.

Srivastava S, Patil A, Prakash C, et al, Comparison of intralesional triamcinolone acetonide, 5-fluorouracil, and their combination in treatment of keloids. World J Plastic Surg. 2018;7(2):212.

Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study. Arch Dermatol Res. 2014;306(9):803-8.

Noishiki C, Hayasaka Y, Ogawa R. Sex differences in keloidogenesis: an analysis of 1659 keloid patients in Japan. Dermatol Ther. 2019;9(4):747-54.

Liu R, Xiao H, Wang R, et al, Risk factors associated with the progression from mild keloids to severe keloids. Chin Med J. 2022;135(07):828-36.

Lu W-s, Zheng X-d, Yao X-h, et al, Clinical and epidemiological analysis of keloids in Chinese patients. Arch Dermatol Res. 2015;307(2):109-14.

Kouotou EA, Nansseu JR, Omona Guissana E, et al, Epidemiology and clinical features of keloids in Black Africans: A nested case–control study from Yaoundé, Cameroon. Int J Dermatol. 2019;58(10):1135-40.

Shaheen A, Khaddam J, Kesh F. Risk factors of keloids in Syrians. BMC Dermatol. 2016;16(1):1-11.

Belie O, Ugburo A, Mofikoya B. Demographic and clinical characteristics of keloids in an urban center in Sub-Sahara Africa. Niger J Clin Pract. 2019;22(8):1049-54.

Nanda S, Reddy BSN. Intralesional 5?fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30(1):54-7.

Bijlard E, Kouwenberg C, Timman R, et al, Burden of keloid disease: a cross-sectional health-related quality of life assessment. Acta DV. 2017;97(2):225-9.

Sharma S, Vinay K, Bassi R. Treatment of small keloids using intralesional 5-fluorouracil and triamcinolone acetonide versus intralesional bleomycin and triamcinolone acetonide. J Clin Aesthet Dermatol. 2021;14(3):17.

Hietanen K, Järvinen T, Huhtala H, et al, Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections–a randomized controlled trial. J Plastic Reconstr Aesthet Surg. 2019;72(1):4-11.

Alexandrescu D, Fabi S, Yeh LC, et al, Comparative Results in Treatment of Keloids With Intralesional 5-FU/Kenalog, 5-FU/Verapamil, Enalapril Alone, Verapamil Alone, and Laser: A Case Report and Review of the Literature. J Drugs in Dermatol. 2016;15(11):1442-7.




How to Cite

Latif, B. D. . ., Saeed , M. Y. ., & Abdulla, D. M. . (2024). Efficacy of intra lesional injection of 5-flourouracil on keloid scar: A prospective open clinical trial. AMJ (Advanced Medical Journal) , 9(2), 112-120. https://doi.org/10.56056/amj.2024.263